Publication Name	World Journal of Gastroenterology
Manuscript ID	20342
Country	Japan

Received	2015-06-02 09:21
Peer-Review Started	2015-06-03 13:14
To Make the First Decision	2015-07-20 13:57
Return for Revision	2015-07-28 11:26
Revised	2015-08-13 12:56
Second Decision	2015-09-23 19:50
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-09-30 08:52
Articles in Press	2015-09-30 08:52
Publication Fee Transferred
Edit the Manuscript by Language Editor	2015-11-05 07:05
Typeset the Manuscript	2015-12-18 17:36
Publish the Manuscript Online	2016-01-06 16:13

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies
Manuscript Source	Invited Manuscript
All Author List	Tasuku Matsuoka and Masakazu Yashiro
Funding Agency and Grant Number	Funding Agency Grant Number Grant-in-Aid for Scientific Research 23390329 (in part)
Corresponding Author	Masakazu Yashiro, MD, Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan. m9312510@med.osaka-cu.ac.jp
Key Words	Pancreatic cancer; Targeted therapy; Tyrosine kinase inhibitors; Microenvironment; Cancer stem cell
Core Tip	Pancreatic cancer-related mortality is almost consistently caused by local recurrence and metastasis. The survival of patients after surgical resection remains poor, and the results of adjuvant chemotherapy and radiotherapy are still unsatisfactory. Therefore, new treatments are urgently needed. Recent developments in our knowledge of the underlying biological features of pancreatic cancer may be useful in establishing molecularly targeted therapy as a new strategy, similar to those used to treat other types of malignancies.
Publish Date	2016-01-06 16:13
Citation	Matsuoka T, Yashiro M. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies. World J Gastroenterol 2016; 22(2): 776-789
URL	http://www.wjgnet.com/1007-9327/full/v22/i2/776.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i2.776

Full Article (PDF)	WJG-22-776.pdf
Full Article (Word)	WJG-22-776.doc
Manuscript File	20342-Review.docx
Answering Reviewers	20342-Answering reviewers.pdf
Audio Core Tip	20342-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	20342-Conflict-of-interest statement.pdf
Copyright License Agreement	20342-Copyright assignment.pdf
Peer-review Report	20342-Peer-review(s).pdf
Scientific Misconduct Check	20342-Scientific misconduct check.pdf
Scientific Editor Work List	20342-Scientific editor work list.pdf